Effect of pre-transplantation use of angiotensin-converting enzyme inhibitor or angiotensin receptor blocker in kidney transplant recipients-propensity score-matched analysis

CONCLUSIONS: In KT, the preoperative use of ACEi/ARBs did not significantly affect clinical outcomes including delayed graft function, postoperative renal function, hyperkalemia events, incidence of rejection, and graft survival rates compared to the patients who did not receive ACEi/ARBs.PMID:38684638 | DOI:10.1007/s40620-024-01938-3

Source: Journal of Nephrology - April 29, 2024 Category: Urology & Nephrology Authors: Jaeyun Lee Chan-Young Jung Hyosang Kim Hwa Jung Kim Youngmin Ko Hyunwook Kwon Sung Shin Young Hoon Kim Su-Kil Park Chung Hee Baek Source Type: research